Chr Hansen: UBS cuts target price
(CercleFinance.com) - While maintaining a "neutral" rating on Danish food ingredients maker Chr Hansen, analysts at UBS have cut their target price for the stock from 565 Danish kronor to 555 Danish kronor, in fear of falling growth in 2017/2018.
"Margin weakness in the first quarter is only a temporary issue in our view but organic risks from US probiotics mount and there is little sign of 2nd generation bioprotection upside," the broker said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
"Margin weakness in the first quarter is only a temporary issue in our view but organic risks from US probiotics mount and there is little sign of 2nd generation bioprotection upside," the broker said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.